Manulife (Manufacturers Life Insurance)
PCRX icon

Manulife (Manufacturers Life Insurance)’s Pacira BioSciences PCRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248K Sell
10,990
-8,149
-43% -$181K ﹤0.01% 2385
2025
Q4 		$495K Sell
19,139
-2,098
-10% -$49.9K ﹤0.01% 2179
2025
Q3 		$547K Sell
21,237
-1,706
-7% -$41.9K ﹤0.01% 2168
2025
Q2 		$548K Buy
22,943
+213
+0.9% +$5.37K ﹤0.01% 2136
2025
Q1 		$565K Buy
22,730
+5,808
+34% +$139K ﹤0.01% 2085
2024
Q4 		$319K Sell
16,922
-458
-3% -$8.04K ﹤0.01% 2422
2024
Q3 		$262K Sell
17,380
-6,552
-27% -$112K ﹤0.01% 2544
2024
Q2 		$685K Buy
23,932
+1,354
+6% +$38.5K ﹤0.01% 2061
2024
Q1 		$660K Sell
22,578
-203
-0.9% -$6.24K ﹤0.01% 2072
2023
Q4 		$769K Sell
22,781
-453
-2% -$13.3K ﹤0.01% 1956
2023
Q3 		$713K Buy
23,234
+4,796
+26% +$173K ﹤0.01% 1943
2023
Q2 		$739K Buy
18,438
+429
+2% +$17.7K ﹤0.01% 1814
2023
Q1 		$735K Buy
18,009
+120
+0.7% +$4.77K ﹤0.01% 1774
2022
Q4 		$691K Buy
17,889
+135
+0.8% +$6.57K ﹤0.01% 1799
2022
Q3 		$944K Sell
17,754
-258
-1% -$14.3K ﹤0.01% 1631
2022
Q2 		$1.05M Sell
18,012
-70
-0.4% -$4.58K ﹤0.01% 1627
2022
Q1 		$1.38M Sell
18,082
-4,289
-19% -$286K ﹤0.01% 1614
2021
Q4 		$1.35K Sell
22,371
-362
-2% -$20K ﹤0.01% 1659
2021
Q3 		$1.27M Sell
22,733
-1,801
-7% -$104K ﹤0.01% 1689
2021
Q2 		$1.49M Buy
24,534
+490
+2% +$31K ﹤0.01% 1748
2021
Q1 		$1.69M Sell
24,044
-1,332
-5% -$95.1K ﹤0.01% 1623
2020
Q4 		$1.52M Buy
25,376
+1,064
+4% +$62.3K ﹤0.01% 1632
2020
Q3 		$1.46M Sell
24,312
-338
-1% -$19.6K ﹤0.01% 1522
2020
Q2 		$1.28M Sell
24,650
-1,377
-5% -$57.5K ﹤0.01% 1526
2020
Q1 		$873K Buy
26,027
+1,652
+7% +$68.6K ﹤0.01% 1572
2019
Q4 		$1.1M Sell
24,375
-697
-3% -$29.6K ﹤0.01% 1624
2019
Q3 		$1M Sell
25,072
-310
-1% -$12.4K ﹤0.01% 1641
2019
Q2 		$1.1M Sell
25,382
-860
-3% -$36.5K ﹤0.01% 1594
2019
Q1 		$999K Buy
26,242
+1,525
+6% +$59.5K ﹤0.01% 1694
2018
Q4 		$1.06M Sell
24,717
-1,479
-6% -$69K ﹤0.01% 1563
2018
Q3 		$1.29M Sell
26,196
-3,841
-13% -$166K ﹤0.01% 1648
2018
Q2 		$963K Buy
30,037
+235
+0.8% +$8.11K ﹤0.01% 1914
2018
Q1 		$928K Sell
29,802
-211
-0.7% -$7.51K ﹤0.01% 1888
2017
Q4 		$1.37M Buy
30,013
+79
+0.3% +$3.13K ﹤0.01% 1669
2017
Q3 		$1.12M Sell
29,934
-373
-1% -$15K ﹤0.01% 1714
2017
Q2 		$1.45M Buy
30,307
+1,872
+7% +$86.9K ﹤0.01% 1594
2017
Q1 		$1.3M Buy
28,435
+3,439
+14% +$149K ﹤0.01% 1612
2016
Q4 		$807K Buy
24,996
+84
+0.3% +$2.8K ﹤0.01% 1782
2016
Q3 		$853K Buy
24,912
+57
+0.2% +$2.23K ﹤0.01% 1734
2016
Q2 		$838K Buy
24,855
+693
+3% +$34.1K ﹤0.01% 1718
2016
Q1 		$1.23M Buy
24,162
+287
+1% +$16.8K ﹤0.01% 1523
2015
Q4 		$1.83K Buy
23,875
+250
+1% +$14.2K ﹤0.01% 1409
2015
Q3 		$971 Buy
23,625
+647
+3% +$39.6K ﹤0.01% 1616
2015
Q2 		$1.63K Sell
22,978
-37,942
-62% -$2.99M ﹤0.01% 1468
2015
Q1 		$5.41K Sell
60,920
-3,877
-6% -$393K 0.01% 1007
2014
Q4 		$5.75K Buy
64,797
+41,669
+180% +$3.94M 0.01% 917
2014
Q3 		$2.24K Buy
23,128
+582
+3% +$56.6K ﹤0.01% 1294
2014
Q2 		$2.07M Buy
22,546
+1,570
+7% +$120K ﹤0.01% 1317
2014
Q1 		$1.47K Sell
20,976
-149
-0.7% -$10.1K ﹤0.01% 1430
2013
Q4 		$1.21K Sell
21,125
-668
-3% -$35.1K ﹤0.01% 1502
2013
Q3 		$1.05K Sell
21,793
-883
-4% -$32.2K ﹤0.01% 1530
2013
Q2 		$658K Buy
+22,676
New +$656K ﹤0.01% 1717

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PCRX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Pacira BioSciences (PCRX) stake by 43% in Q1 2026, selling an estimated $181K and leaving 10,990 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #2385.

Manulife (Manufacturers Life Insurance) first reported a position in PCRX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.07M in Q2 2014. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 10,990 shares of Pacira BioSciences worth $248K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 8,149 Pacira BioSciences shares in Q1 2026, an estimated $181K.
  • Pacira BioSciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2385 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Pacira BioSciences in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Pacira BioSciences position peaked at $2.07M in Q2 2014.
  • 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.